Peripheral pathways in the food-intake control towards the adipose-intestinal missing link

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Mendieta Zerón, Hugo ^a,b   Domínguez García, Ma Victoria ^a   Camarillo Romero, María Del Socorro ^a   Flores Merino, Miriam V ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^b Ciprés Grupo Médico CGM   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893846482     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/598203     Document Type: Review

References (130)

1. Ramsey K. M., Marcheva B., Kohsaka A., Bass J., The clockwork of metabolism. Annual Review of Nutrition 2007 27 219 240 2-s2.0-38449103255 10.1146/annurev.nutr.27.061406.093546 (Pubitemid 351373356)
2. Kyithar M. P., Dinneen S. F., ACP Journal Club. An intensive lifestyle intervention increased remission from type 2 diabetes in overweight adults. Annals of Internal Medicine 2013 158 10, article JC4 10.7326/0003-4819-158-10- 201305210-02004
3. De Silva A., Bloom S. R., Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut and Liver 2012 6 1 10 20 2-s2.0-84856080046 10.5009/gnl.2012.6.1.10
4. Delzenne N., Blundell J., Brouns F., Cunningham K., De Graaf K., Erkner A., Lluch A., Mars M., Peters H. P. F., Westerterp-Plantenga M., Gastrointestinal targets of appetite regulation in humans: ILSI supplement. Obesity Reviews 2010 11 3 234 250 2-s2.0-77649085155 10.1111/j.1467-789X.2009. 00707.x
5. Zheng H., Berthoud H. R., Eating for pleasure or calories. Current Opinion in Pharmacology 2007 7 6 607 612 2-s2.0-36549027795 10.1016/j.coph.2007. 10.011 (Pubitemid 350177559)
6. Johnson K. H., O'Brien T. D., Westermark P., Newly identified pancreatic protein islet amyloid polypeptide: what is its relationship to diabetes? Diabetes 1991 40 3 310 314 2-s2.0-0026020109
7. Koda J. E., Fineman M., Rink T. J., Dailey G. E., Muchmore D. B., Linarelli L. G., Amylin concentrations and glucose control [21]. Lancet 1992 339 8802 1179 1180 2-s2.0-0026581265 10.1016/0140-6736(92)90785-2
8. Lutz T. A., Amylinergic control of food intake. Physiology and Behavior 2006 89 4 465 471 2-s2.0-33750355471 10.1016/j.physbeh.2006.04.001 (Pubitemid 44634569)
9. Morley J. E., Flood J. F., Horowitz M., Morley P. M. K., Walter M. J., Modulation of food intake by peripherally administered amylin. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1994 267 1, part 2 R178 R184 2-s2.0-0028060577
10. Smith S. R., Blundell J. E., Burns C., Ellero C., Schroeder B. E., Kesty N. C., Chen K. S., Halseth A. E., Lush C. W., Weyer C., Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. American Journal of Physiology-Endocrinology and Metabolism 2007 293 2 E620 E627 2-s2.0-34547621757 10.1152/ajpendo.00217.2007 (Pubitemid 47205106)
11. Wielinga P. Y., Alder B., Lutz T. A., The acute effect of amylin and salmon calcitonin on energy expenditure. Physiology and Behavior 2007 91 2-3 212 217 2-s2.0-34248647047 10.1016/j.physbeh.2007.02.012 (Pubitemid 46770799)
12. Poyner D. R., Sexton P. M., Marshall I., Smith D. M., Quirion R., Born W., Muff R., Fischer J. A., Foord S. M., International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews 2002 54 2 233 246 2-s2.0-0036266044 10.1124/pr.54.2.233 (Pubitemid 34575714)
13. Hilton J. M., Dowton M., Houssami S., Sexton P. M., Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. Journal of Endocrinology 2000 166 1 213 226 2-s2.0-0033946363 (Pubitemid 30435891)
14. Riediger T., Schmid H. A., Lutz T. A., Simon E., Amylin and glucose co-activate area postrema neurons of the rat. Neuroscience Letters 2002 328 2 121 124 2-s2.0-0037047491 10.1016/S0304-3940(02)00482-2 (Pubitemid 34804726)
15. Lomenick J. P., Melguizo M. S., Mitchell S. L., Summar M. L., Anderson J. W., Effects of meals high in carbohydrate, protein, and fat on ghrelin and peptide YY secretion in prepubertal children. Journal of Clinical Endocrinology and Metabolism 2009 94 11 4463 4471 2-s2.0-70449097602 10.1210/jc.2009-0949
16. Germain N., Galusca B., Grouselle D., Frere D., Billard S., Epelbaum J., Estour B., Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2010 95 6 3057 3062 2-s2.0-77954520777 10.1210/jc.2009-2196
17. Tomasik P. J., Sztefko K., Starzyk J., Entero-insular axis in children with simple obesity. Pediatric Endocrinology, Diabetes and Metabolism 2009 15 2 63 69 2-s2.0-70349924080
18. Santillan-Benitez J. G., Mendieta-Zeron H., Gomez-Olivan L. M., Torres-Juárez J. J., González-Bañales J. M., Hernández-Peña L. V., Ordóñez-Quiroz A., The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer. Journal of Clinical Laboratory Analysis 2013 27 1 12 20 10.1002/jcla.21555
19. Beasley J. M., Ange B. A., Anderson C. A. M., Miller E. R. III, Holbrook J. T., Appel L. J., Characteristics associated with fasting appetite hormones (obestatin, Ghrelin, and Leptin). Obesity 2009 17 2 349 354 2-s2.0-58849136572 10.1038/oby.2008.551
20. Oliván B., Teixeira J., Bose M., Bawa B., Chang T., Summe H., Lee H., Laferrère B., Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Annals of Surgery 2009 249 6 948 953 2-s2.0-67649207401 10.1097/SLA.0b013e3181a6cdb0
21. de Luis D., Pacheco D., Conde R., Primo D., Aller R., Izaola O., Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery. Annals of Nutrition and Metabolism 2012 61 1 70 73 10.1159/000339378
22. Martins C., Kjelstrup L., Mostad I. L., Kulseng B., Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients. Obesity Surgery 2011 21 6 751 758 2-s2.0-79956188007 10.1007/s11695-011-0399-9
23. Korner J., Inabnet W., Febres G., Conwell I. M., McMahon D. J., Salas R., Taveras C., Schrope B., Bessler M., Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. International Journal of Obesity 2009 33 7 786 795 2-s2.0-67650417904 10.1038/ijo.2009.79
24. Hill B. R., de Souza M. J., Williams N. I., Characterization of the diurnal rhythm of peptide YY and its association with energy balance parameters in normal-weight premenopausal women. American Journal of Physiology- Endocrinology and Metabolism 2011 301 2 E409 E415 2-s2.0-79960796791 10.1152/ajpendo.00171.2011
25. Belalcazar L. M., Ballantyne C. M., Lang W., Haffner S. M., Rushing J., Schwenke D. C., Pi-Sunyer F. X., Tracy R. P., Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 7 1689 1695 2-s2.0-79959729276 10.1161/ATVBAHA.111.224386
26. Baggio L. L., Drucker D. J., Biology of Incretins: GLP-1 and GIP. Gastroenterology 2007 132 6 2131 2157 2-s2.0-34248223285 10.1053/j.gastro.2007. 03.054 (Pubitemid 46711096)
27. Cuntz U., Enck P., Frühauf E., Lehnert P., Riepl R. L., Fichter M. M., Otto B., Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa. PLoS One 2013 8 1 10.1371/journal.pone.0054457 e54457
28. Raybould H. E., Glatzle J., Freeman S. L., Whited K., Darcel N., Liou A., Bohan D., Detection of macronutrients in the intestinal wall. Autonomic Neuroscience 2006 125 1-2 28 33 2-s2.0-33646141841 10.1016/j.autneu.2006.01.016
29. Geary N., Endocrine controls of eating: CCK, leptin, and ghrelin. Physiology and Behavior 2004 81 5 719 733 2-s2.0-3042543651 10.1016/j.physbeh. 2004.04.013 (Pubitemid 38845039)
30. Brown T. A. L., Washington M. C., Metcalf S. A., Sayegh A. I., The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves. Peptides 2011 32 8 1581 1586 2-s2.0-80051547601 10.1016/j.peptides. 2011.06.024
31. Gómez R., Navarro M., Ferrer B., Trigo J. M., Bilbao A., Arco I. D., Cippitelli A., Nava F., Piomelli D., De Fonseca F. R., A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. Journal of Neuroscience 2002 22 21 9612 9617 2-s2.0-0036849961 (Pubitemid 35356203)
32. Di Marzo V., Capasso R., Matias I., Aviello G., Petrosino S., Borrelli F., Romano B., Orlando P., Capasso F., Izzo A. A., The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. British Journal of Pharmacology 2008 153 6 1272 1280 2-s2.0-40949147440 10.1038/sj.bjp.0707682 (Pubitemid 351415503)
33. Paulino G., De La Serre C. B., Knotts T. A., Oort P. J., Newman J. W., Adams S. H., Raybould H. E., Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. American Journal of Physiology-Endocrinology and Metabolism 2009 296 4 E898 E903 2-s2.0-65649151443 10.1152/ajpendo.90796.2008
34. Izzo A. A., Piscitelli F., Capasso R., Aviello G., Romano B., Borrelli F., Petrosino S., Di Marzo V., Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. British Journal of Pharmacology 2009 158 2 451 461 2-s2.0-68349129115 10.1111/j.1476-5381.2009.00183.x
35. Cluny N. L., Vemuri V. K., Chambers A. P., Limebeer C. L., Bedard H., Wood J. T., Lutz B., Zimmer A., Parker L. A., Makriyannis A., Sharkey K. A., A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. British Journal of Pharmacology 2010 161 3 629 642 2-s2.0-77956037652 10.1111/j.1476-5381.2010.00908.x
36. Yu J. H., Kim M. S., Molecular mechanisms of appetite regulation. Diabetes and Metabolism Journal 2012 36 6 391 398 10.4093/dmj.2012.36.6.391
37. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 6762 656 660 2-s2.0-0033540056 10.1038/45230 (Pubitemid 129516334)
38. Burdyga G., Varro A., Dimaline R., Thompson D. G., Dockray G. J., Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006 290 6 G1289 G1297 2-s2.0-33646856625 10.1152/ajpgi.00543. 2005 (Pubitemid 43788312)
39. Le Roux C. W., Patterson M., Vincent R. P., Hunt C., Ghatei M. A., Bloom S. R., Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. Journal of Clinical Endocrinology and Metabolism 2005 90 2 1068 1071 2-s2.0-14044262360 10.1210/jc.2004-1216 (Pubitemid 40279235)
40. Cummings D. E., Weigle D. S., Scott Frayo R., Breen P. A., Ma M. K., Patchen Dellinger E., Purnell J. Q., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 21 1623 1630 2-s2.0-0037162116 10.1056/NEJMoa012908 (Pubitemid 34755670)
41. Hwa J. J., Fawzi A. B., Graziano M. P., Ghibaudi L., Williams P., Van Heek M., Davis H., Rudinski M., Sybertz E., Strader C. D., Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1997 272 4 R1204 R1209 2-s2.0-0030920206
42. Deacon C. F., Ahrén B., Physiology of incretins in health and disease. Review of Diabetic Studies 2011 8 3 293 306 2-s2.0-84856023179 10.1900/RDS.2011.8.293
43. Lluis F., Fujimura M., Gomez G., Salvá J. A., Greeley G. H. Jr., Thompson J. C., Cellular localization, half-life, and secretion of peptide YY. Revista Española de Fisiología 1989 45 4 377 384 (Pubitemid 20124947)
44. Dailey M. J., Moran T. H., Glucagon-like peptide 1 and appetite. Trends in Endocrinology and Metabolism 2013 24 2 85 91 10.1016/j.tem.2012.11.008
45. Mansour A., Hosseini S., Larijani B., Pajouhi M., Mohajeri-Tehrani M. R., Nutrients related to GLP1 secretory responses. Nutrition 2013 29 6 813 820 10.1016/j.nut.2012.11.015
46. Labouesse M. A., Stadlbauer U., Weber E., Arnold M., Langhans W., Pacheco-López G., Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. Journal of Neuroendocrinology 2012 24 12 1505 1516 10.1111/j.1365-2826.2012. 02364.x
47. Rocca A. S., Brubaker P. L., Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999 140 4 1687 1694 2-s2.0-0032982267 (Pubitemid 29149238)
48. Pocai A., Unraveling oxyntomodulin, GLP1's enigmatic brother. Journal of Endocrinology 2012 215 3 335 346 10.1530/JOE-12-0368
49. Baggio L. L., Huang Q., Brown T. J., Drucker D. J., Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 2004 127 2 546 558 2-s2.0-4143116741 10.1053/j.gastro.2004.04.063 (Pubitemid 39091903)
50. Dakin C. L., Small C. J., Batterham R. L., Neary N. M., Cohen M. A., Patterson M., Ghatei M. A., Bloom S. R., Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004 145 6 2687 2695 2-s2.0-2542460293 10.1210/en.2003-1338 (Pubitemid 38686215)
51. Wynne K., Park A. J., Small C. J., Patterson M., Ellis S. M., Murphy K. G., Wren A. M., Frost G. S., Meeran K., Ghatei M. A., Bloom S. R., Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes 2005 54 8 2390 2395 2-s2.0-23644443678 10.2337/diabetes.54.8.2390 (Pubitemid 41134267)
52. Batterham R. L., Bloom S. R., The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences 2003 994 162 168 2-s2.0-0038727630 (Pubitemid 36793863)
53. Adrian T. E., Ferri G. L., Bacarese-Hamilton A. J., Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985 89 5 1070 1077 2-s2.0-0022398837 (Pubitemid 16231572)
54. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., Beglinger C., Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005 129 5 1430 1436 2-s2.0-27744584314 10.1053/j.gastro.2005. 09.001 (Pubitemid 41597385)
55. Essah P. A., Levy J. R., Sistrun S. N., Kelly S. M., Nestler J. E., Effect of macronutrient composition on postprandial peptide YY levels. Journal of Clinical Endocrinology and Metabolism 2007 92 10 4052 4055 2-s2.0-35348973470 10.1210/jc.2006-2273 (Pubitemid 47607660)
56. Helou N., Obeid O., Azar S. T., Hwalla N., Variation of postprandial PYY3-36 response following ingestion of differing macronutrient meals in obese females. Annals of Nutrition and Metabolism 2008 52 3 188 195 2-s2.0-47249110795 10.1159/000138122 (Pubitemid 351990888)
57. Batterham R. L., Cohen M. A., Ellis S. M., Le Roux C. W., Withers D. J., Frost G. S., Ghatei M. A., Bloom S. R., Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine 2003 349 10 941 948 2-s2.0-0041859261 10.1056/NEJMoa030204 (Pubitemid 37064767)
58. Dunmore S. J., Brown J. E., The role of adipokines in beta-cell failure of type 2 diabetes. Journal of Endocrinology 2013 216 1 T37 T45 10.1530/JOE-12-0278
59. Pajvani U. B., Du X., Combs T. P., Berg A. H., Rajala M. W., Schulthess T., Engel J., Brownlee M., Scherer P. E., Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity. Journal of Biological Chemistry 2003 278 11 9073 9085 2-s2.0-0037984387 10.1074/jbc.M207198200 (Pubitemid 36800387)
60. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 25 2473 2476 2-s2.0-0033613545 (Pubitemid 30005109)
61. Fruhbeck G., Peptides in Energy Balance and Obesity 2009 Wallingford, UK CABI Publishing
62. Robinson K., Prins J., Venkatesh B., Clinical review: adiponectin biology and its role in inflammation and critical illness. Critical Care 2011 15 2, article 221 10.1186/cc10021
63. Paz-Filho G., Mastronardi C., Franco C. B., Wang K. B., Wong M. L., Licinio J., Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Archivos Brasileiros de Endocrinologia y Metabología 2012 56 9 597 607 10.1590/S0004-27302012000900001
64. Santillán Benítez J. G., Ordóñez Quiroz A., Mendieta Zerón H., Gómez Oliván L. M., La leptina en la carcinogénesis mamaria vías de señalización. Química Viva 2012 11 2 91 111
65. Coppari R., Bjorbaek C., Leptin revisited: its mechanism of action and potential for treating diabetes. Nature Reviews Drug Discovery 2012 11 9 692 708 10.1038/nrd3757
66. Margetic S., Gazzola C., Pegg G. G., Hill R. A., Leptin: a review of its peripheral actions and interactions. International Journal of Obesity 2002 26 11 1407 1433 2-s2.0-0036866913 10.1038/sj.ijo.0802142 (Pubitemid 36007818)
67. González-Jiménez E., Aguilar Cordero M. J., Padilla Lopez C. A., Garcia G. I, Monogenic human obesity: role of the leptin-melanocortin system in the regulation of food intake and body weight in humans. Anales del Sistema Sanitario de Navarra 2012 35 2 285 293 10.1038/nrd3757
68. Bouret S. G., Bates S. H., Chen S., Myers M. G. Jr., Simerly R. B., Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. Journal of Neuroscience 2012 32 4 1244 1252 2-s2.0-84856297723 10.1523/JNEUROSCI.2277-11.2012
69. Minokoshi Y., Alquier T., Furukawa H., Kim Y. B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M. J., Stuck B. J., Kahn B. B., AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004 428 6982 569 574 2-s2.0-1842484296 10.1038/nature02440 (Pubitemid 38480541)
70. Andersson U., Filipsson K., Abbott C. R., Woods A., Smith K., Bloom S. R., Carling D., Small C. J., AMP-activated protein kinase plays a role in the control of food intake. Journal of Biological Chemistry 2004 279 13 12005 12008 2-s2.0-1842582870 10.1074/jbc.C300557200 (Pubitemid 38445761)
71. Cox C. L., Stanhope K. L., Schwarz J. M., Graham J. L., Hatcher B., Griffen S. C., Bremer A. A., Berglund L., McGahan J. P., Keim N. L., Havel P. J., Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. Journal of Clinical Endocrinology and Metabolism 2011 96 12 E2034 E2038 2-s2.0-83155168431 10.1210/jc.2011-1050
72. Lutz T. A., Control of food intake and energy expenditure by amylin-therapeutic implications. International Journal of Obesity 2009 33 supplement 1 S24 S27 2-s2.0-64949171578 10.1038/ijo.2009.13
73. Neary N. M., Small C. J., Druce M. R., Park A. J., Ellis S. M., Semjonous N. M., Dakin C. L., Filipsson K., Wang F., Kent A. S., Frost G. S., Ghatei M. A., Bloom S. R., Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005 146 12 5120 5127 2-s2.0-27844508598 10.1210/en.2005-0237 (Pubitemid 41653025)
74. Furuta H., Combination therapy of amylin and leptin. Nihon Rinsho 2012 70 supplement 3 740 745
75. Bermúdez V., Bermúdez F., Arraiz N., Biología molecular de los transportadores de glucosa: clasificación, estructura y distribución. Archivos Venezolanos de Farmacología y Terapéutica 2007 26 2 1 11
76. Lowe M. E., Pancreatic triglyceride lipase and colipase: insights into dietary fat digestion. Gastroenterology 1994 107 5 1524 1536 2-s2.0-0028034916 (Pubitemid 24328294)
77. Tundis R., Loizzo M. R., Menichini F., Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Reviews in Medicinal Chemistry 2010 10 4 315 331 2-s2.0-77956629122
78. Hanhineva K., Törrönen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkänen H., Poutanen K., Impact of dietary polyphenols on carbohydrate metabolism. International Journal of Molecular Sciences 2010 11 4 1365 1402 2-s2.0-77951934925 10.3390/ijms11041365
79. de Sales P. M., de Souza P. M., Simeoni L. A., Magalhães P. D. O., Silveira D., α -amylase inhibitors: a review of raw material and isolated compounds from plant source. Journal of Pharmacy and Pharmaceutical Sciences 2012 15 1 141 183 2-s2.0-84857082127
80. Ha K. S., Jo S. H., Kang B. H., Apostolidis E., Lee M. S., Jang H. D., Kwon Y. I., In vitro and in vivo antihyperglycemic effect of 2 amadori rearrangement compounds, arginyl-fructose and arginyl-fructosyl-glucose. Journal of Food Science 2011 76 8 H188 H193 2-s2.0-80054759067 10.1111/j.1750-3841. 2011.02361.x
81. Adisakwattana S., Jiphimai P., Prutanopajai P., Chanathong B., Sapwarobol S., Ariyapitipan T., Evaluation of α -glucosidase, α -amylase and protein glycation inhibitory activities of edible plants. International Journal of Food Sciences and Nutrition 2010 61 3 295 305 2-s2.0-77951476280 10.3109/09637480903455963
82. Grussu D., Stewart D., McDougall G. J., Berry polyphenols inhibit α -amylase in vitro: identifying active components in rowanberry and raspberry. Journal of Agricultural and Food Chemistry 2011 59 6 2324 2331 2-s2.0-79952765315 10.1021/jf1045359
83. Akkarachiyasit S., Yibchok-Anun S., Wacharasindhu S., Adisakwattana S., In vitro inhibitory effects of cyandin-3-rutinoside on pancreatic α -amylase and its combined effect with acarbose. Molecules 2011 16 3 2075 2083 2-s2.0-79953083787 10.3390/molecules16032075
84. Adisakwattana S., Lerdsuwankij O., Poputtachai U., Minipun A., Suparpprom C., Inhibitory activity of cinnamon bark species and their combination effect with acarbose against Intestinal α -glucosidase and Pancreatic α -amylase. Plant Foods for Human Nutrition 2011 66 2 143 148 2-s2.0-79960168451 10.1007/s11130-011-0226-4
85. Gómez L., Molinar-Toribio E., Calvo-Torras M. A., Adelantado C., Juan M. E., Planas J. M., Cañas X., Lozano C., Pumarola S., Clapés P., Torres J. L., D-Fagomine lowers postprandial blood glucose and modulates bacterial adhesion. British Journal of Nutrition 2012 107 12 1739 1746 10.1017/S0007114511005009
86. Matsui T., Ebuchi S., Kobayashi M., Fukui K., Sugita K., Terahara N., Matsumoto K., Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cultivar ayamurasaki can be achieved through the α -glucosidase inhibitory action. Journal of Agricultural and Food Chemistry 2002 50 25 7244 7248 2-s2.0-0037021603 10.1021/jf025913m (Pubitemid 35424884)
87. Adisakwattana S., Charoenlertkul P., Yibchok-Anun S., α -glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose. Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 1 65 69 2-s2.0-58949088520 10.1080/14756360801906947
88. Ali K. M., Chatterjee K., De D., Jana K., Bera T. K., Ghosh D., Inhibitory effect of hydro-methanolic extract of seed of Holarrhena antidysenterica on alpha-glucosidase activity and postprandial blood glucose level in normoglycemic rat. Journal of Ethnopharmacology 2011 135 1 194 196 2-s2.0-79955466721 10.1016/j.jep.2011.02.034
89. Ryu H. W., Cho J. K., Curtis-Long M. J., Yuk H. J., Kim Y. S., Jung S., Kim Y. S., Lee B. W., Park K. H., α -Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry 2011 72 17 2148 2154 2-s2.0-80053649817 10.1016/j.phytochem.2011. 08.007
90. Park C. H., Noh J. S., Tanaka T., Uebaba K., Cho E. J., Yokozawa T., The effects of corni fructus extract and its fractions against α -glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats. American Journal of Chinese Medicine 2011 39 2 367 380 2-s2.0-79953646449 10.1142/S0192415X11008889
91. Sugiyama H., Akazome Y., Shoji T., Yamaguchi A., Yasue M., Kanda T., Ohtake Y., Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption. Journal of Agricultural and Food Chemistry 2007 55 11 4604 4609 2-s2.0-34250639118 10.1021/jf070569k (Pubitemid 46932661)
92. Ikarashi N., Takeda R., Ito K., Ochiai W., Sugiyama K., The inhibition of lipase and glucosidase activities by acacia polyphenol. Evidence-Based Complementary and Alternative Medicine 2011 2011 8 2-s2.0-79953282391 10.1093/ecam/neq043 272075
93. Klijs B., Otto S. J., Heine R. J., van der Graaf Y., Lous J. J., de Koning H. J., Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial. BMC Public Health 2012 12 article 671 10.1186/1471-2458-12-671
94. Schienkiewitz A., Mensink G. B., Scheidt-Nave C., Comorbidity of overweight and obesity in a nationally representative sample of German adults aged 18-79 years. BMC Public Health 2012 12 article 658 10.1186/1471-2458-12-658
95. Kwak S. H., Kim S. H., Cho Y. M., Go M. J., Cho Y. S., Choi S. H., Moon M. K., Jung H. S., Shin H. D., Kang H. M., Cho N. H., Lee I. K., Kim S. Y., Han B. G., Jang H. C., Park K. S., A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 2012 61 2 531 541 2-s2.0-84856557191 10.2337/db11-1034
96. Oteng-Ntim E., Varma R., Croker H., Poston L., Doyle P., Lifestyle interventions for overweight and obese pregnant women to improve pregnancy outcome: systematic review and meta-analysis. BMC Medicine 2012 10 article 47 10.1186/1741-7015-10-47
97. Pi-Sunyer X., Blackburn G., Brancati F. L., Bray G. A., Bright R., Clark J. M., Curtis J. M., Espeland M., Foreyt J. P., Graves K., Haffner S. M., Harrison B., Hill J. O., Horton E. S., Jakicic J., Jeffery R. W., Johnson K. C., Kahn S., Kelley D. E., Kitabchi A. E., Knowler W. C., Lewis C. E., Maschak-Carey B. J., Montgomery B., Nathan D. M., Patricio J., Peters A., Redmon J. B., Reeves R. S., Ryan D. H., Safford M., Van Dorsten B., Wadden T. A., Wagenknecht L., Wesche-Thobaben J., Wing R. R., Yanovski S. Z., Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007 30 6 1374 1383 2-s2.0-34249864128 10.2337/dc07-0048 (Pubitemid 46871141)
98. Klein S., Sheard N. F., Pi-Sunyer X., Daly A., Wylie-Rosett J., Kulkarni K., Clark N. G., Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies-a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care 2004 27 8 2067 2073 2-s2.0-3343024281 10.2337/diacare.27.8.2067 (Pubitemid 38989258)
99. Camastra S., Manco M., Mari A., Baldi S., Gastaldelli A., Greco A. V., Mingrone G., Ferrannini E., β -cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005 54 8 2382 2389 2-s2.0-23644457358 10.2337/diabetes.54.8.2382 (Pubitemid 41134266)
100. Polonsky K. S., Gumbiner B., Ostrega D., Griver K., Tager H., Henry R. R., Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes 1994 43 7 871 877 2-s2.0-0028339912 (Pubitemid 24196418)
101. Garrow J. S., Treatment of morbid obesity by nonsurgical means: diet, drugs, behavior modification, exercise. Gastroenterology Clinics of North America 1987 16 3 443 449 2-s2.0-0023612991 (Pubitemid 18094624)
102. Geloneze B., Pareja J. C., Does bariatric surgery cure the metabolic syndrome? Arquivos Brasileiros de Endocrinologia e Metabologia 2006 50 2 400 407 2-s2.0-33744468249 10.1590/S0004-27302006000200026 (Pubitemid 43799123)
103. Pories W. J., MacDonald K. G. Jr., Morgan E. J., Sinha M. K., Dohm G. L., Swanson M. S., Barakat H. A., Khazanie P. G., Leggett-Frazier N., Long S. D., O'Brien K. F., Caro J. F., Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. American Journal of Clinical Nutrition 1992 55 2 582S 585S 2-s2.0-0026500361
104. Sjöström L., Lindroos A. K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., Dahlgren S., Larsson B., Narbro K., Sjöström C. D., Sullivan M., Wedel H., Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 26 2683 2693 2-s2.0-10844295087 10.1056/NEJMoa035622 (Pubitemid 39665322)
105. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M. D., Pories W. J., Bantle J. P., Sledge I., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009 122 3 248 256 2-s2.0-61549094077 10.1016/j.amjmed.2008.09.041
106. Schauer P. R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., Eid G. M., Mattar S., Ramanathan R., Barinas-Mitchel E., Rao R. H., Kuller L., Kelley D., Saar M. G., Meguid M. A., Buchwald H., Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 4 467 485 2-s2.0-10744222607 (Pubitemid 38176385)
107. Sugerman H. J., Wolfe L. G., Sica D. A., Clore J. N., Gleysteen J. J., O'Leary J. P., Griffen W. O. Jr., Pories W. J., Macdonald K. G., Lineaweaver W. C., Sugerman H. J., Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Annals of Surgery 2003 237 6 751 756 2-s2.0-0038790272 10.1097/00000658-200306000-00002 (Pubitemid 38174509)
108. Nathan D. M., Initial management of glycemia in type 2 diabetes mellitus. New England Journal of Medicine 2002 347 17 1342 1349 2-s2.0-0037167920 10.1056/NEJMcp021106 (Pubitemid 35215326)
109. Cummings D. E., Weigle D. S., Frayo R. S., Breen P. A., Ma M. K., Patchen Dellinger E., Purnell J. Q., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 21 1623 1630 2-s2.0-0037162116 10.1056/NEJMoa012908 (Pubitemid 34755670)
110. Rubino F., Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes care 2008 31 supplement 2 S290 S296 2-s2.0-41149129233
111. Hickey M. S., Pories W. J., MacDonald K. G. Jr., Cory K. A., Dohm G. L., Swanson M. S., Israel R. G., Barakat H. A., Considine R. V., Caro J. F., Houmard J. A., A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Annals of Surgery 1998 227 5 637 644 2-s2.0-0031740324 10.1097/00000658-199805000-00004 (Pubitemid 28530913)
112. Rubino F., Gagner M., Gentileschi P., Kini S., Fukuyama S., Feng J., Diamond E., The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Annals of Surgery 2004 240 2 236 242 2-s2.0-0842303191 10.1097/01.sla.0000133117.12646.48 (Pubitemid 38963013)
113. Oliván B., Teixeira J., Bose M., Bawa B., Chang T., Summe H., Lee H., Laferrère B., Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Annals of Surgery 2009 249 6 948 953 2-s2.0-67649207401 10.1097/SLA.0b013e3181a6cdb0
114. Colman R. J., Anderson R. M., Johnson S. C., Kastman E. K., Kosmatka K. J., Beasley T. M., Allison D. B., Cruzen C., Simmons H. A., Kemnitz J. W., Weindruch R., Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009 325 5937 201 204 2-s2.0-67650439330 10.1126/science. 1173635
115. Pories W. J., Albrecht R. J., Etiology of type II diabetes mellitus: role of the foregut. World Journal of Surgery 2001 25 4 527 531 2-s2.0-0034998738 10.1007/s002680020348 (Pubitemid 32455209)
116. Valverde I., Puente J., Martín-Duce A., Molina L., Lozano O., Sancho V., Malaisse W. J., Villanueva-Peñacarrillo M. L., Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obesity Surgery 2005 15 3 387 397 2-s2.0-16244400156 10.1381/0960892053576613 (Pubitemid 40463608)
117. Rubino F., Gagner M., Gentileschi P., Kini S., Fukuyama S., Feng J., Diamond E., The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Annals of Surgery 2004 240 2 236 242 2-s2.0-0842303191 10.1097/01.sla.0000133117.12646.48 (Pubitemid 38963013)
118. Mendieta-Zerón H., Larrad-Jiménez Á., Burrell M. A., Rodríguez M. M., Da Boit K., Frühbeck G., Diéguez C., Biliopancreatic diversion induces villi elongation and cholecystokinin and ghrelin increase. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2012 5 2 66 70 2-s2.0-84859712056 10.1016/j.dsx.2012.02.012
119. Falkén Y., Hellström P. M., Holst J. J., Näslund E., Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. Journal of Clinical Endocrinology and Metabolism 2011 96 7 2227 2235 2-s2.0-79960088798 10.1210/jc.2010-2876
120. Polyzogopoulou E. V., Kalfarentzos F., Vagenakis A. G., Alexandrides T. K., Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003 52 5 1098 1103 2-s2.0-0242684706 10.2337/diabetes.52.5.1098 (Pubitemid 36523342)
121. Laferrère B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., Hart A. B., Olivan B., Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007 30 7 1709 1716 2-s2.0-34447132026 10.2337/dc06-1549 (Pubitemid 47036341)
122. Cases J. A., Gabriely I., Ma X. H., Yang X. M., Michaeli T., Fleischer N., Rossetti L., Barzilai N., Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001 50 2 348 352 2-s2.0-0035125097 (Pubitemid 32140441)
123. Schenk S., Saberi M., Olefsky J. M., Insulin sensitivity: modulation by nutrients and inflammation. Journal of Clinical Investigation 2008 118 9 2992 3002 2-s2.0-51349156218 10.1172/JCI34260
124. Sjöström C. D., Lissner L., Wedel H., Sjöström L., Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obesity Research 1999 7 5 477 484 2-s2.0-0033191062 (Pubitemid 129710611)
125. Griffen W. O. Jr., Bivins B. A., Bell R. M., Jackson K. A., Gastric bypass for morbid obesity. World Journal of Surgery 1981 5 6 817 822 2-s2.0-0019803849 (Pubitemid 12109061)
126. Rubino F., Gagner M., Potential of surgery for curing type 2 diabetes mellitus. Annals of Surgery 2002 236 5 554 559 2-s2.0-0036829857 10.1097/00000658-200211000-00003 (Pubitemid 35246885)
127. Hui H., Wright C., Perfetti R., Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001 50 4 785 796 2-s2.0-0035084164 (Pubitemid 32242635)
128. Wright E. M., Martín M. G., Turk E., Intestinal absorption in health and disease-sugars. Bailliere's Best Practice and Research in Clinical Gastroenterology 2003 17 6 943 956 2-s2.0-0347983829 10.1016/S1521-6918(03) 00107-0
129. Hotamisligil G. S., Mechanisms of TNF- α -induced insulin resistance. Experimental and Clinical Endocrinology and Diabetes 1999 107 2 119 125 2-s2.0-0032925340 (Pubitemid 29179278)
130. Chaudhri O. B., Wynne K., Bloom S. R., Can gut hormones control appetite and prevent obesity? Diabetes care 2008 31 supplement 2 S284 S289 2-s2.0-41149115559